Manufacturer record
Dm Pharma Private Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Dm Pharma Private Limited (Himachal Pradesh) were declared Not of Standard Quality between October 2022 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
10 records linked to Dm Pharma Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin & Ornidazole Tablets IP | DT241211BMfg 2024-08 · Exp 2026-07 | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab | Feb 2026 |
| Tranexamic Acid & Mefenamic Acid Tablets (Trancycle-MF) | DMT1127Mfg 2023-08 · Exp 2025-07 | AssayAssay | CDTL HyderabadCDSCO lab | Jan 2024 |
| Trypsin, Bromelain & Rutoside Trihydrate Tablets (Rednil) | DMT1197BMfg 2023-08 · Exp 2025-07 | Assay/content of 'Trypsin'Assay | CDL KolkataCDSCO lab | Dec 2023 |
| Etoricoxib & Thiocolchicoside Tablets (ATOCOX-MR Tablets) | DMT1202BMfg 2023-08 · Exp 2025-07 | Assay of ThiocolchicosideAssay | CDL KolkataCDSCO lab | Oct 2023 |
| Trypsin-Chymotrypsin Tablets (Chymnetra-Forte) | DT1624HMfg 2022-12 · Exp 2024-11 | Uniformity of Weight, & Average WeightUniformity of weight/content | CDTL MumbaiCDSCO lab | Jul 2023 |
| Chymovit Forte (Trypsin- Chymotrypsin Tablets) | DMT0027 JMfg 2023-01 · Exp 2024-12 | Uniformity of Weight, Average Weight & Disintegration test (Acid stage)Disintegration | CDTL MumbaiCDSCO lab | Jul 2023 |
| Telmisartan Tablets IP 40 mg (TLS-40 TABLETS) | DT0862BMfg 2022-07 · Exp 2024-06 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jun 2023 |
| Paediatric Paracetamol Oral Suspension BP (PARA 120 SUSPENSION) | D10086Mfg 2021-10 · Exp 2024-09 | Related Substances and Assay of ParacetamolAssay | RDTL ChandigarhCDSCO lab | Dec 2022 |
| Paediatric Paracetamol Oral Suspension BP (PARA 120 SUSPENSION) | D10085Mfg 2021-10 · Exp 2024-09 | Related Substances and Assay of ParacetamolAssay | RDTL ChandigarhCDSCO lab | Dec 2022 |
| Esolip 40 (Esomeprazole Gastro-Resistant Tablets IP 40 mg) | TGD210190Mfg 2021-03 · Exp 2023-02 | AssayAssay | RDTL GuwahatiState lab | Oct 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.